9 3 39 (Lamotrigine 25 mg)
Pill with imprint 9 3 39 is White, Four-sided and has been identified as Lamotrigine 25 mg. It is supplied by Teva Pharmaceuticals USA.
Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 9 3 39
Lamotrigine
- Imprint:
- 9 3 39
- Strength:
- 25 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- Triazine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-0039
- Inactive Ingredients:
-
- silicon dioxide
- lactose monohydrate
- magnesium stearate
- microcrystalline cellulose
- povidone k30
- corn starch
- sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
More about lamotrigine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1241 Reviews
- Drug class: triazine anticonvulsants
- FDA Alerts (5)
Consumer resources
- Lamotrigine
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Orally Disintegrating Tablets
- Lamotrigine Tablets
- Lamotrigine (Advanced Reading)
Other brands: Lamictal, Lamictal XR, Lamictal CD, Lamictal ODT, Subvenite
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
